Champions Oncology Inc
NASDAQ:CSBR 1:19:19 PM EDT
| Market Cap (Intraday) | 135.02M |
| Current PE | 1,174.12 |
| Forward PE | 83.83 |
| 2yr Forward PE | 40.24 |
| 10-Day MA | $10.11 |
| 50-Day MA | $10.24 |
| 200-Day MA | $10.59 |
Champions Oncology Inc Stock, NASDAQ:CSBR
One University Plaza, Suite 307, Hackensack, New Jersey 07601
United States of America
Phone: +1.201.808.8400
Number of Employees: 194
Description
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.